| BASIC/CLINICAL SCIENCE LAM CONFERENCE, MARCH 22-24, 2002 | |||||
| Conference Chairs | Frank McCormack, MD Elizabeth Henske, MD Eugene Sullivan, MD |
|
|||
| Session I | Smooth Muscle | Chair, Ray Panettieri, MD | |||
![]() |
Talmadge King, Jr., MD | "What is known about the presentation, pathogenesis and treatment of LAM" | |||
| Deborah Hunter, PhD | "What is known about the molecular and cellular biology of LAM" | ||||
| Marvin Schwarz, MD | "Smooth muscle infiltration in interstitial lung disease" | ||||
| Presentations | Blanca Camoretti-Mercado, PhD | "Over-expression of Tuberin Regulates Promoter Activity of the Key Enzyme in the Mevalonate Pathway in Airway Smooth Muscle Cells" | |||
| Angelo Taveira-DaSilva, MD, PhD | "Maximum Oxygen Uptake (VO2max) As A Test Of Severity Of Disease In Lymphangioleiomyomatosis (LAM). " | ||||
| Session Keynote | Kurt R. Stenmark, MD | "Control of vascular smooth muscle cell proliferation indevelopment and disease" | |||
| Session II | Hormones | Chair, Blanca Camoretti-Mercado, PhD | |||
| Session Keynote | Donald McDonnell, PhD | "Estrogen receptor-cofactor interactions as targets for new drug discovery" | |||
| Session Keynote | Richard Santen, MD | "How does estrogen cause cells to grow?" | |||
| Presentations | Geraldine Finlay, MD | "Autocrine production of platelet-derived growth factor potentiates MAP kinase activation to mediate estrogen-induced proliferation of ELT-3 cells" | |||
![]() |
Guillermo Flores-Delgado, PhD | "Nongenomic Estrogen Action In Lung Myofibroblasts Stimulates Erk1/2 Map Kinase And Igfr Phosphorylation" | |||
| Nancy Ayres Rice, PhD | "Transcriptional regulation of skeletal muscle myosin expression in pulmonary myofibroblasts" | ||||
| Brian Fouty, MD | "TRAIL induces apoptosis in LAM- like cells" | ||||
| Session III | Cell Biology | Chair, Jilly Evans, PhD | |||
| Session Keynote | Richard Lamb, PhD | "Functions of TSC tumour suppressor proteins and possible relationships to LAM pathology" |
|||
| Session Keynote | Joel Moss, MD, PhD | "NHLBI intramural research program" | |||
| Janet Maurer, MD | "Lung transplantation in LAM" | ||||
| Presentations | Jeanine D'Armiento, MD, PhD | "A Transgenic Mouse Model of Pulmonary Lymphangiomyomatosis (LAM)" | |||
![]() |
Jonathan Moreno, MD, PhD | ||||
| Vera Krymskaya, PhD | "Determinants of Elastin Production by Smooth Muscle Cells" | ||||
| Merv Merrilees, MD | "Tuberin Regulates Activation Of S6K1 And Ribosomal Protein S6" | ||||
| Session IV | TSC and Genetics | Chair, Deborah Hunter, PhD | |||
| Session Keynote | Dicky Halley, PhD | "LAM and TSC: a genetic relationship?" | |||
| Session Keynote | Mark Brantly, MD | "Issues in clinical trial design for rare diseases" | |||
| Presentations | Aristotelis Astrinidis, PhD | "Tuberin Regulates Rho Activation, Cell Adhesion, and Cell Migration" | |||
![]()
|
Nisreen El-Hashemite, PhD | "A TSC1 mouse model reveals sex dependent lethality from Liver Hemangioma: a future model for LAM" | |||
| Magdalena Karbowniczek, MD, PhD | "Renal Angiomyolipomas from Women with Sporadic Lymphangiomyomatosis Contain Both Neoplastic and Reactive Vascular Structures" | ||||
| Dan Noonan, PhD | "Molecular Analyses of TSC2-Mediated Intracellular Signaling Pathways" | ||||
| Vijaya Ramesh, PhD | "Pam (Protein Associated With Myc), A Novel Interactor For TSC2 Protein Tuberin" | ||||
| Posters | Jane Yu, PhD | Estrogen Stimulates the Growth of Cultured Cells from Lymphangiomyomatosis-Associated Angiomyolipoma | |||
|
|
James Michael Shipley, PhD | Disruption of TSC2 Function in Adult Mice | |||
| Marsha Cohen, MD, FRCPC | Preliminary results of a survey to assess Psychosocial Outcomes Pre and Post Lung Transplant for women with LAM | ||||
| John Bissler, MD | Replication Consequences of a Polypurine·Polypyrimidine Tract Near the TSC2 Gene | ||||
| Eric Olson, MD | Chylothorax in Lymphangioleiomyomatosis | ||||
| Nicole Griffith, MS | Construction of TSC1 and TSC2 Adenovirus Clones | ||||